Synopsys (NASDAQ:SNPS) is set to announce its earnings results after the market closes on Wednesday, February 21st. Analysts expect the company to announce earnings of $1.00 per share for the quarter. Synopsys has set its Q1 guidance at $0.98-1.02 EPS.
Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, November 29th. The semiconductor company reported $0.69 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.57 by $0.12. Synopsys had a net margin of 5.01% and a return on equity of 5.78%. The firm had revenue of $696.60 million during the quarter, compared to the consensus estimate of $650.72 million. During the same quarter in the previous year, the firm posted $0.77 earnings per share. The company’s revenue was up 9.9% on a year-over-year basis. On average, analysts expect Synopsys to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Shares of Synopsys (NASDAQ SNPS) opened at $89.07 on Tuesday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.04 and a current ratio of 1.04. Synopsys has a 12 month low of $68.79 and a 12 month high of $94.80. The firm has a market cap of $13,250.00, a P/E ratio of 103.57, a PEG ratio of 3.97 and a beta of 1.04.
Several analysts have recently weighed in on SNPS shares. Royal Bank of Canada raised shares of Synopsys from an “outperform” rating to a “top pick” rating and lifted their price target for the company from $90.00 to $100.00 in a research note on Wednesday, October 25th. DA Davidson reaffirmed a “buy” rating and set a $105.00 price target (up previously from $91.00) on shares of Synopsys in a research note on Tuesday, November 28th. Needham & Company LLC lifted their price target on shares of Synopsys from $83.00 to $100.00 and gave the company a “buy” rating in a research note on Thursday, November 30th. KeyCorp reaffirmed an “overweight” rating and set a $106.00 price target (up previously from $86.00) on shares of Synopsys in a research note on Thursday, November 30th. Finally, TheStreet downgraded shares of Synopsys from an “a” rating to a “c+” rating in a research note on Wednesday, November 29th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company. Synopsys currently has a consensus rating of “Hold” and an average price target of $96.89.
In related news, CEO Chi-Foon Chan sold 3,750 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $89.78, for a total value of $336,675.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Joseph W. Logan sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $90.33, for a total transaction of $451,650.00. The disclosure for this sale can be found here. Insiders sold 65,442 shares of company stock valued at $5,779,693 in the last three months. 1.82% of the stock is currently owned by insiders.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/20/synopsys-snps-scheduled-to-post-quarterly-earnings-on-wednesday.html.
Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.